EORTC Lung Cancer Group Spring Meeting

Malaga, Spain

The EORTC Lung Cancer Group Spring Meeting will be held in Malaga, Spain on 16-18 May 2024 and is only open to individual or site staff members of the group.

Registrations for the meeting are open and the link was sent by email. In case you are an individual or site staff member of the EORTC Lung Cancer Group, and you have not received the registration link, please contact

Venue: Rectorado de la Universidad de Málaga


Thursday 16 MAY – Spring meeting day 1

Location: Rectorado de la Universidad de Málaga
Avenida de Cervantes 2
29015 Málaga, Spain

Time slot Topic / Title of presentation Speaker

10h30 – 17h30


10h30 Arrival and registration
11h00 – 13h15 Y-ECI Meeting Part I
11h00 – 11h15 Coffee & Introduction Anne-Marie Dingemans
11h15 – 11h45 Rare thoracic cancers: what future research opportunities? Nicolas Gerard
11h45 – 12h15 Older patients in clinical trials: advantages and challenges? Lissandra Dal Lago
12h15 – 13h15

Round-a-Table Mentorship sessions (1h in total)

  • Transition from training to being a specialist (incl. Time / priorities management)
  • How to lead your own research program (lab and/or clinical research)

Anne-Marie Dingemans, Jordi Remon, Lizza Hendriks

Jose Manuel Trigo

13h15 – 14h00 Lunch break
14h00 – 18h00 Y-ECI Meeting Part II
14h00 – 15h00 Meet the Editor: tips & tricks for publication in high-impact journals Diana Romero
15h00 – 16h00 Interaction with the industry (1 hour depending on attendance by industry) Representatives of Amgen – Roche
16h00 – 17h30

Discussion of 3 to 4 clinical trial proposals (1 to 1.5 hour in total; 5 min presentation + 15 min discussion):

Radiotherapy in stage III thymic tumors according to IX TNM (Valeria Dionisi)

Osimertinib after CRT guided by liquid biopsy (Laura Moliner)

Phase 2 trial comparing lobectomy vs neoadjuvant SBRT followed by segmentectomy or atypical resection (Elena Prisciandaro / Niccolo Giaj-Levra)

Phase II trial of first line cemiplimab+ axelopran, a peripherally active mu-opioid receptor antagonist – PAMORA, in opioid-exposed patients with PD-L1 ≥ 50% non-small cell lung cancer (NSCLC) (Alessio Cortellini)

LCG Faculty:

Anne-Marie Dingemans

Jordi Remon

Corinne Faivre-Finn

Giannis Mountzios

Jose Manuel Trigo

LCG Board members

18h00 – 20h00 Board Meeting LCG Board Members
21h00 Y-ECI Dinner – together with LCG board members and all speakers


Friday 17 MAY – Spring meeting day 2

Location: Rectorado de la Universidad de Málaga
Avenida de Cervantes 2
29015 Málaga, Spain

Time slot Topic / Title of presentation Speaker

11h00 – 13h00

EORTC-LCG Meeting Part I

11h00 Arrival and registration
11h30 – 11h40 Introduction and welcome Anne-Marie Dingemans
11h40 – 12h00 Performance, update on members, enrolling sites, queries Anne-Marie Dingemans
12h00 – 12h25 Y-ECI update (including Elections) Mariana Brandao
12h25 – 13h00

Update on ongoing studies:

  • EORTC 2029 (ICARS)
  • EORTC 1702 (HALT)
  • EORTC 1901 (PRIMAlung)
  • EORTC 1553 (SPECTA)

Natalia Rueda

13h00 – 13h30

Protocols in (pre-) development:

EORTC 37%4 Stage III Platform


EORTC 2346 Teliso Brain


Mariana Brandao

Anne-Marie Dingemans

Lizza Hendriks

13h30 – 15h30 Lunch break

15h30 – 19h30

EORTC-LCG Symposium

15h30 Arrival and registration non-member delegates
15h30 – 17h00 EORTC-LCG Symposium Part I
15h40 – 15h45 Introduction

Chair: Anne-Marie Dingemans ; Co-Chair : Jose Carlos Benitez

15h45 – 16h00 Resectable stage disease Mariana Brandao
16h00 – 16h15 Challenges with the ICB in the peri-operative strategy Jordi Remon
16h15 – 16h30 Challenges to implement perioperative strategy, surgical point of view TBC
16h30 – 16h45 De-escalating treatment strategies with ICB Benjamin Besse
16h45 – 17h00 Questions All
17h00 – 17h25 Coffee Break
17h25 – 19h15 EORTC-LCG Symposium Part II
17h25 – 17h30 Introduction

Chair: Anne-Marie Dingemans ; Co-Chair : Jose Carlos Benitez

17h30 – 17h45 Risk of Brain Mets Lizza Hendriks
17h45 – 18h00 Quality of Life Cecilia Pompili
18h15 – 18h30 Artificial intelligence in pathology Jan von der Thusen
18h30 – 18h45 ADCs Noemi Reguart
18h45 – 19h00 New trials with radiotherapy and ICB in the early-stage and stage III Corinne Faivre-Finn
19h00 – 19h15 Round-a-table All
19h15 – 19h30 Closing remarks Anne-Marie Dingemans
19h30 Dinner for members only


Saturday 18 MAY – Spring meeting day 3

Location: Rectorado de la Universidad de Málaga
Avenida de Cervantes 2
29015 Málaga, Spain

Time slot Topic / Title of presentation Speaker

08h30 – 13h00

EORTC-LCG Meeting Part II

09h00 Arrival and registration
09h30 – 09h45 Introduction and welcome

Jordi Remon & Thierry Berghmans

09h45 – 10h30

New proposals:





(d)escalation in (neo)adjuvant treatment treatment of early-stage lung adenocarcinoma.


Early versus delayed treatment with immunotherapy of relapsed cancers: 3 randomized trials (Innovative Heal Initiative call)

Jonas Willmann

Martin Igor Gomez-Randulfe Rodriguez

Anne-Marie Dingemans / Jordi Remon

Idris Bahce

Jan von der Thüsen

Corinne Faivre Finn

Benjamin Besse

10h30 – 11h00 Coffee Break
11h00 – 11h40

Brainstorming on future studies

Neoadjuvant/Peri-operative setting

Uncommon EGFR mutations


NSCLC & Brain metastases

Anne-Marie Dingemans

Jordi Remon

11h40 – 12h00 Close Out Anne-Marie Dingemans
12h00 – 13h00 Farewell lunch


Next events

  • The 10+1 Santorini Conference


  • EACR Annual Congress 2024

    Rotterdam, Netherlands

  • Clinical Trial Statistics for Non-Statisticians

    Brussels, BE

  • EORTC Leukemia Group Spring Meeting 2024

    Madrid, ES

  • 24th Workshop on Methods in Clinical Cancer Research (MCCR)

    Sint Michielgestel, Netherlands